Comparison Study of COVID-19 Pandemic Scenario in Emerging Market and Regulatory Market
International Journal of Pharmaceutical and Phytopharmacological Research
; 11(6):1-7, 2021.
Article
in English
| EMBASE | ID: covidwho-1885015
ABSTRACT
The corona virus (COVID-19) pandemic, a zoonotic disease transmitted from bat to human originated in Wuhan, China, has rapidly spread to several countries, with various cases having been reported globally. The second wave of the corona virus is spreading like a tsunami and is growing at an alarming rate compared to the first wave. It has been seen that the mutant virus is more transmissible and its incubation period is shorter. This article mainly deals with the number of people affected in the 1st and 2nd waves of COVID-19 in India and other countries. The study included all the cases reported from March 3, 2020 - August 31, 2021. The condition of the USA is even more critical than India, Brazil, Russia, United Kingdom, France, Turkey, Argentina, Italy, and other countries. The US has reported the highest number of cases (38,802,453) while Colombia has reported the lowest number of cases (4,905,258).
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
International Journal of Pharmaceutical and Phytopharmacological Research
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS